{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:45:45Z","timestamp":1788561945544,"version":"build-2803163510"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127340","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:16:06Z","timestamp":1748884566000},"page":"127340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates"],"prefix":"10.1016","volume":"61","author":[{"given":"Amir Ghaffari","family":"Jolfayi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Aminizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mohammad","family":"Yaghoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Sohrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ghahramanipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Yousefimoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127340_bb0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00262-011-1023-5","article-title":"Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study","volume":"60","author":"Bauer","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127340_bb0010","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1097\/CM9.0000000000001226","article-title":"Advances and challenges in antiretroviral therapy for acquired immunodeficiency syndrome","volume":"133","author":"Bai","year":"2020","journal-title":"Chin Med J"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127340_bb0015","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/17512433.2019.1698946","article-title":"Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States","volume":"12","author":"Masters","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0020","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.158.6.2723","article-title":"Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules","volume":"158","author":"Shen","year":"1997","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2025.127340_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117580","article-title":"Dendritic cell therapy in cancer treatment; the state-of-the-art","volume":"254","author":"Sadeghzadeh","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.vaccine.2025.127340_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02993","article-title":"Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?","volume":"9","author":"da Silva","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020158","article-title":"Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells","volume":"12","author":"Calmeiro","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2025.127340_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719664","article-title":"New approaches to dendritic cell-based therapeutic vaccines against HIV-1 infection","volume":"12","author":"Espinar-Buitrago","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0045","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/s41467-019-13368-y","article-title":"Engineering dendritic cell vaccines to improve cancer immunotherapy","volume":"10","author":"Perez","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/jiq077","article-title":"A therapeutic dendritic cell-based vaccine for HIV-1 infection","volume":"203","author":"Garc\u00eda","year":"2011","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2025.127340_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172147","article-title":"Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations","volume":"12","author":"Lee","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2012.04.009","article-title":"Development of antigen cross-presentation capacity in dendritic cells","volume":"33","author":"Dresch","year":"2012","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0075","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.immuni.2014.04.016","article-title":"Development and function of dendritic cell subsets","volume":"40","author":"Mildner","year":"2014","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127340_bb0080","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1084\/jem.20091586","article-title":"Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network","volume":"206","author":"Chorro","year":"2009","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0085","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ni1522","article-title":"Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo","volume":"8","author":"Naik","year":"2007","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0732s99","article-title":"Isolation and generation of human dendritic cells","volume":"99","author":"Nair","year":"2012","journal-title":"Curr Protoc Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.it.2017.07.007","article-title":"Dendritic cells as inducers of peripheral tolerance","volume":"38","author":"Iberg","year":"2017","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/2326-6066.CIR-13-0102","article-title":"Dendritic cells: master regulators of the immune response","volume":"1","author":"Mellman","year":"2013","journal-title":"Cancer immunology research"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ni880","article-title":"Functional interactions between dendritic cells and NK cells during viral infection","volume":"4","author":"Andrews","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2006.00450.x","article-title":"Effector and regulatory events during natural killer\u2013dendritic cell interactions","volume":"214","author":"Moretta","year":"2006","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0115","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2006-06-026385","article-title":"Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell\u2013natural killer cell crosstalk","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.127340_bb0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev-immunol-020711-074929","article-title":"Molecular control of steady-state dendritic cell maturation and immune homeostasis","volume":"31","author":"Hammer","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri.2016.100","article-title":"Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis","volume":"16","author":"Cadwell","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0130","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.0900438","article-title":"Crucial contribution of thymic Sirp\u03b1+ conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner","volume":"183","author":"Baba","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","article-title":"Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo","volume":"194","author":"Hawiger","year":"2001","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0145","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-3083.2007.01909.x","article-title":"The cross-priming pathway: a portrait of an intricate immune system","volume":"65","author":"Basta","year":"2007","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1074-7613(03)00171-7","article-title":"TNF\/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection","volume":"19","author":"Serbina","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.127340_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-540-71029-5_3","article-title":"Dendritic cells in viral infections","author":"Belz","year":"2009","journal-title":"Dendritic cells"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2006.03.014","article-title":"Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization","volume":"24","author":"He","year":"2006","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0170","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","article-title":"Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions","volume":"162","author":"Eickhoff","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20040370","article-title":"A contribution of mouse dendritic cell\u2013derived IL-2 for NK cell activation","volume":"200","author":"Granucci","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20010938","article-title":"Reciprocal activating interaction between natural killer cells and dendritic cells","volume":"195","author":"Gerosa","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0966-842X(02)02441-1","article-title":"Successful control of viruses by NK cells\u2013a balance of opposing forces?","volume":"10","author":"Scalzo","year":"2002","journal-title":"Trends Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20011672","article-title":"Interferon \u03b1\/\u03b2 and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo","volume":"195","author":"Dalod","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0195","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ni1244","article-title":"Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity","volume":"6","author":"Andoniou","year":"2005","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fvl.15.2","article-title":"A mechanistic overview of dendritic cell-mediated HIV-1 trans infection: the story so far","volume":"10","author":"Kijewski","year":"2015","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12022","article-title":"Mechanisms of enhanced HIV spread through T-cell virological synapses","volume":"251","author":"Dale","year":"2013","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127340_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082131","article-title":"The 12 item social and economic conservatism scale (SECS)","volume":"8","author":"Everett","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1074-7613(02)00259-5","article-title":"DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection","volume":"16","author":"Kwon","year":"2002","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/aid.2015.0235","article-title":"Dendritic cells enhance HIV infection of memory CD4+ T cells in human lymphoid tissues","volume":"32","author":"Reyes-Rodriguez","year":"2016","journal-title":"AIDS Res Hum Retrovir"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127340_bb0225","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N","article-title":"Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation","volume":"28","author":"Sallusto","year":"1998","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0230","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ni841","article-title":"Diversity of receptors binding HIV on dendritic cell subsets","volume":"3","author":"Turville","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127340_bb0235","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3389\/fimmu.2019.01306","article-title":"Role of dendritic cells in natural immune control of HIV-1 infection","volume":"10","author":"Martin-Gayo","year":"2019","journal-title":"Front Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127340_bb0240","first-page":"3839","article-title":"Evidence of dysregulation of dendritic cells in primary HIV infection","volume":"116","author":"Sabado","year":"2010","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127340_bb0245","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1084\/jem.20110654","article-title":"Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo","volume":"208","author":"Swiecki","year":"2011","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.humimm.2016.05.019","article-title":"Lymph nodes from HIV-infected individuals harbor mature dendritic cells and increased numbers of PD-L1+ conventional dendritic cells","volume":"77","author":"Carranza","year":"2016","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0255","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/QAI.0b013e31817f97cf","article-title":"Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients","volume":"48","author":"Lehmann","year":"2008","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0260","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/infdis\/jis384","article-title":"Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-\u03b1 and differentiate into functional killer pDCs under HIV activation","volume":"206","author":"Barblu","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0265","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2005-03-1243","article-title":"CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon\u2013dependent, TRAIL\/DR5-mediated apoptosis","volume":"106","author":"Herbeuval","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.127340_bb0270","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2018.02759","article-title":"Combination strategies to optimize efficacy of dendritic cell-based immunotherapy","volume":"9","author":"Van Gulijk","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0275","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0280","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1395124","article-title":"Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade","volume":"7","author":"Nagaoka","year":"2018","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87059","article-title":"PD-1 blockade enhances the vaccination-induced immune response in glioma","volume":"1","author":"Antonios","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2025.127340_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.613773","article-title":"Dendritic cell vaccines in ovarian cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0295","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s12094-020-02344-4","article-title":"Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment","volume":"22","author":"Rodriguez Perez","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2017.05.006","article-title":"Integrating next-generation dendritic cell vaccines into the current cancer immunotherapy landscape","volume":"38","author":"Garg","year":"2017","journal-title":"Trends Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0305","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/14712598.2014.950652","article-title":"Advances in dendritic cell immunotherapies for HIV-1 infection","volume":"14","author":"Miller","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2025.127340_bb0310","article-title":"Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19","volume":"146","author":"Saadeldin","year":"2021","journal-title":"A hypothesis Medical hypotheses"},{"key":"10.1016\/j.vaccine.2025.127340_bb0315","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12026-017-8931-1","article-title":"Dendritic cell-based immunotherapy: a basic review and recent advances","volume":"65","author":"Constantino","year":"2017","journal-title":"Immunol Res"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0320","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0325","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/1078-0432.CCR-10-3421","article-title":"Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In VivoPeptide-Loaded LC versus moDC Anti-Melanoma Vaccines","volume":"17","author":"Romano","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0330","first-page":"00036","article-title":"Dendritic Cell Therapy: A Proactive Approach against Cancer Immunotherapy","volume":"1","author":"Varma","year":"2016","journal-title":"J Stem Cell Res Ther"},{"key":"10.1016\/j.vaccine.2025.127340_bb0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molimm.2018.03.027","article-title":"Antigen processing and presentation in HIV infection","volume":"113","author":"Boucau","year":"2019","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0340","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells:\u201cl'union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.127340_bb0345","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s00262-005-0089-3","article-title":"NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity","volume":"55","author":"Osada","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2025.127340_bb0355","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","article-title":"The PD-1\/PD-L1 axis and virus infections: a delicate balance","volume":"9","author":"Sch\u00f6nrich","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2567.2000.00121.x","article-title":"CD28, CTLA-4 and their ligands: who does what and to whom?","volume":"101","author":"Sansom","year":"2000","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0365","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1128\/JVI.72.10.7992-8001.1998","article-title":"Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins","volume":"72","author":"Rossio","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127340_bb0370","first-page":"261","article-title":"Cross-presentation of cell-associated antigens by dendritic cells","volume":"276","author":"Larsson","year":"2003","journal-title":"Curr Top Microbiol Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127340_bb0375","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1128\/JVI.75.19.8949-8956.2001","article-title":"In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells","volume":"75","author":"Lu","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0380","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/eji.200636981","article-title":"Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1","volume":"37","author":"Sabado","year":"2007","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0385","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4161\/hv.25876","article-title":"Dendritic cell based vaccines for HIV infection: the way ahead","volume":"9","author":"Garc\u00eda","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"27","key":"10.1016\/j.vaccine.2025.127340_bb0390","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.0501050102","article-title":"CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse","volume":"102","author":"Pacheco","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0395","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1189\/jlb.1009696","article-title":"Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells","volume":"89","author":"Martinez-Navio","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0400","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/icb.2009.53","article-title":"Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV","volume":"87","author":"Climent","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.127340_bb0405","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-5793(00)01751-8","article-title":"The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression","volume":"477","author":"Blanco","year":"2000","journal-title":"FEBS Lett"},{"issue":"166","key":"10.1016\/j.vaccine.2025.127340_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garc\u00eda","year":"2013","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0415","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00002030-200207050-00003","article-title":"Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus","volume":"16","author":"Larsson","year":"2002","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0420","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/JVI.76.6.3007-3014.2002","article-title":"Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells","volume":"76","author":"Zhao","year":"2002","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127340_bb0425","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0304860101","article-title":"Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes","volume":"101","author":"Mara\u00f1\u00f3n","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0430","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/vim.2006.0052","article-title":"Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile","volume":"20","author":"Gruber","year":"2007","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0435","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nri11308","article-title":"Death-defying immunity: do apoptotic cells influence antigen processing and presentation?","volume":"4","author":"Albert","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127340_bb0440","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/infdis\/jiv582","article-title":"Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells","volume":"213","author":"Macatangay","year":"2016","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0445","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CVI.00066-08","article-title":"Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection","volume":"16","author":"Whiteside","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0450","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/cr.2016.157","article-title":"Dendritic cell-based immunotherapy","volume":"27","author":"Sabado","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2025.127340_bb0455","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1054-3589(07)55011-8","article-title":"Role of Nef in HIV-1 replication and pathogenesis","volume":"55","author":"Foster","year":"2007","journal-title":"Adv Pharmacol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0460","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/mr.60.2.386-406.1996","article-title":"Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions","volume":"60","author":"Chirmule","year":"1996","journal-title":"Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127340_bb0465","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1128\/JVI.75.9.4413-4419.2001","article-title":"Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells","volume":"75","author":"Fan","year":"2001","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0470","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/088922299310520","article-title":"Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses","volume":"15","author":"Zheng","year":"1999","journal-title":"AIDS Res Hum Retrovir"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0475","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.vaccine.2007.11.040","article-title":"The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS","volume":"26","author":"Gavioli","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0480","first-page":"998","article-title":"Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma","volume":"9","author":"Butterfield","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0485","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.4049\/jimmunol.180.5.3585","article-title":"Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells","volume":"180","author":"Carrasco","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0490","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2010","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030590","article-title":"Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting","volume":"12","author":"Baldin","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030418","article-title":"Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses","volume":"11","author":"Hossain","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: a promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0510","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00018-012-1100-8","article-title":"Cross-presentation of IgG-containing immune complexes","volume":"70","author":"Baker","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0515","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/JVI.75.3.1301-1311.2001","article-title":"Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif","volume":"75","author":"Altfeld","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0520","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.00221-07","article-title":"Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals","volume":"15","author":"Connolly","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2025.127340_bb0525","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2010.11.002","article-title":"Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine","volume":"365","author":"Cobb","year":"2011","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0530","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.165.8.4710","article-title":"HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response","volume":"165","author":"Weissman","year":"2000","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0535","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2005-04-1513","article-title":"Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef","volume":"107","author":"Kavanagh","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0540","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2005-01-0339","article-title":"Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins","volume":"107","author":"Van Gulck","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0545","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000852","article-title":"Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial","volume":"71","author":"Gandhi","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0550","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12977-018-0388-3","article-title":"The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4(+) T cells","volume":"15","author":"Pawlak","year":"2018","journal-title":"Retrovirology"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127340_bb0555","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/eji.200636782","article-title":"Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag","volume":"37","author":"Melhem","year":"2007","journal-title":"Eur J Immunol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2025.127340_bb0560","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jim.2007.01.004","article-title":"An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes","volume":"321","author":"Milano","year":"2007","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0565","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2567.2004.01823.x","article-title":"DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response","volume":"112","author":"de Arruda","year":"2004","journal-title":"Immunology"},{"issue":"39","key":"10.1016\/j.vaccine.2025.127340_bb0570","doi-asserted-by":"crossref","first-page":"37926","DOI":"10.1074\/jbc.M303336200","article-title":"HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses","volume":"278","author":"Marques","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0575","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1084\/jem.20041270","article-title":"Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells","volume":"200","author":"Lichterfeld","year":"2004","journal-title":"J Exp Med"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127340_bb0580","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1073\/pnas.0402431101","article-title":"HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation","volume":"101","author":"Granelli-Piperno","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0585","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2003.11.021","article-title":"Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression","volume":"319","author":"Nguyen","year":"2004","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0590","first-page":"94","article-title":"Codon usage-mediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation","volume":"45","author":"Kofman","year":"2003","journal-title":"Tsitologiia"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0595","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/aid.2017.0071","article-title":"Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection","volume":"34","author":"Gay","year":"2018","journal-title":"AIDS Res Hum Retrovir"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127340_bb0600","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.gt.3302750","article-title":"Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA","volume":"13","author":"Michiels","year":"2006","journal-title":"Gene Ther"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127340_bb0605","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1073\/pnas.0708874105","article-title":"MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation","volume":"105","author":"De Gassart","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.127340_bb0610","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","article-title":"TNF\/TNFR family members in costimulation of T cell responses","volume":"23","author":"Watts","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0615","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.gt.3302874","article-title":"Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells","volume":"14","author":"Bontkes","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2025.127340_bb0620","series-title":"Handbook of Cancer and Immunology","first-page":"1","article-title":"Exploring the Potential of Neoantigen-Targeted Immunotherapies in Rare Cancers","author":"Ghaffari Jolfayi","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127340_bb0625","article-title":"Recent Advances in Immune Regulation by Targeting Dendritic Cells using Small Interfering RNAs","author":"Shahverdi","year":"2024","journal-title":"Curr Mol Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0630","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2016.12.004","article-title":"HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells","volume":"25","author":"Wee","year":"2017","journal-title":"Mol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0635","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ymthe.2019.03.008","article-title":"Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice","volume":"27","author":"Norton","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.127340_bb0640","first-page":"1","article-title":"Exploiting dendritic cells for active immunotherapy of cancer and chronic infection","volume":"109","author":"O'Neill","year":"2005","journal-title":"Methods Mol Med"},{"issue":"43","key":"10.1016\/j.vaccine.2025.127340_bb0645","first-page":"6088","volume":"27","author":"Gandhi","year":"2009","journal-title":"A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0650","first-page":"473","volume":"203","author":"Garc\u00eda","year":"2011","journal-title":"A therapeutic dendritic cell-based vaccine for HIV-1 infection"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0655","first-page":"31","volume":"72","author":"Jacobson","year":"2016","journal-title":"Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA: a randomized, double-blind, placebo-controlled clinical trial"},{"key":"10.1016\/j.vaccine.2025.127340_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767370","article-title":"Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon \u03b1-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial","volume":"12","author":"Leal","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0665","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/vim.2011.0044","article-title":"Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection","volume":"25","author":"Pe\u00f1a","year":"2012","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2025.127340_bb0670","unstructured":"medicine, N.l.o., Dendritic Cell Vaccine in HIV-1 Infection. 2014."},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0675","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-023-00631-z","article-title":"Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality","volume":"8","author":"Laeremans","year":"2023","journal-title":"npj Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127340_bb0680","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1084\/jem.20061519","article-title":"APOBEC3G\/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection","volume":"203","author":"Pion","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2025.127340_bb0685","article-title":"New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection","volume":"12","author":"Espinar-Buitrago","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0690","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm0703-861","article-title":"Immunopathogenesis and immunotherapy in AIDS virus infections","volume":"9","author":"Letvin","year":"2003","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127340_bb0695","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1084\/jem.20031947","article-title":"Progress in defining CD4 helper cell responses in chronic viral infections","volume":"198","author":"Day","year":"2003","journal-title":"J Exp Med"},{"issue":"6673","key":"10.1016\/j.vaccine.2025.127340_bb0700","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127340_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198403","article-title":"Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine","volume":"298","author":"Sadat Larijani","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127340_bb0710","series-title":"Production of dendritic cell vaccines using different methods with equivalent results: Implications for emerging centers","author":"Duarte","year":"2022"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0715","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ymthe.2017.10.019","article-title":"CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape","volume":"26","author":"Pettitt","year":"2018","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0720","article-title":"An Update on the HIV DNA Vaccine Strategy","volume":"9","author":"Hokello","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127340_bb0725","doi-asserted-by":"crossref","first-page":"9470102","DOI":"10.1155\/2020\/9470102","article-title":"The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook","volume":"2020","author":"Mohamed","year":"2020","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011345","article-title":"Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing","volume":"5","author":"Hedskog","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127340_bb0735","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/aid.2015.0189","article-title":"Analysis of Dominant HIV Quasispecies Suggests Independent Viral Evolution Within Spinal Granulomas Coinfected with Mycobacterium tuberculosis and HIV-1 Subtype C","volume":"32","author":"Danaviah","year":"2016","journal-title":"AIDS Res Hum Retrovir"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181702","article-title":"Barriers and facilitators of HIV vaccine and prevention study participation among Young Black MSM and transwomen in New York City","volume":"12","author":"Richardson","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0745","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/fvl.12.127","article-title":"Impact of age on markers of HIV-1 disease","volume":"8","author":"Pirrone","year":"2013","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0750","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12977-016-0326-1","article-title":"Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a \"stochastic\" process","volume":"14","author":"Gonzalez","year":"2017","journal-title":"Retrovirology"},{"issue":"21","key":"10.1016\/j.vaccine.2025.127340_bb0755","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127340_bb0760","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.vaccine.2025.127340_bb0765","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"issue":"177","key":"10.1016\/j.vaccine.2025.127340_bb0770","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0775","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0780","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41467-023-36109-8","article-title":"HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC","volume":"14","author":"Bissa","year":"2023","journal-title":"Nat Commun"},{"issue":"10160","key":"10.1016\/j.vaccine.2025.127340_bb0785","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/S0140-6736(18)32205-0","article-title":"Implementation research: new imperatives and opportunities in global health","volume":"392","author":"Theobald","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127340_bb0790","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1128\/JVI.03235-14","article-title":"Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission","volume":"89","author":"Gonzalez","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0795","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1128\/JVI.02711-15","article-title":"Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus Macaques","volume":"90","author":"Smith","year":"2016","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127340_bb0800","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.20021924","article-title":"Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha","volume":"198","author":"Lapenta","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127340_bb0805","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nri1960","article-title":"Dendritic-cell interactions with HIV: infection and viral dissemination","volume":"6","author":"Wu","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0810","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127340_bb0815","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0b013e32834f33e8","article-title":"mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients","volume":"26","author":"Van Gulck","year":"2012","journal-title":"Aids"},{"key":"10.1016\/j.vaccine.2025.127340_bb0820","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12967-015-0392-5","article-title":"A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques","volume":"13","author":"Mothe","year":"2015","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029717","article-title":"CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control","volume":"7","author":"Mothe","year":"2012","journal-title":"PLoS One"},{"issue":"7632","key":"10.1016\/j.vaccine.2025.127340_bb0830","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127340_bb0835","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s13063-019-3940-0","article-title":"Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy","volume":"20","author":"de Jong","year":"2019","journal-title":"Trials"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127340_bb0840","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.4049\/jimmunol.147.12.4047","article-title":"The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2","volume":"147","author":"Bednarek","year":"1991","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127340_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7100402","article-title":"Dendritic Cells\/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach","volume":"7","author":"Olukitibi","year":"2019","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216949","article-title":"Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses","volume":"14","author":"Ao","year":"2019","journal-title":"PLoS One"},{"issue":"47","key":"10.1016\/j.vaccine.2025.127340_bb0855","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2014.09.010","article-title":"Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses","volume":"32","author":"Climent","year":"2014","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2025.127340_bb0860","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1128\/JVI.00472-12","article-title":"Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs","volume":"86","author":"De Keersmaecker","year":"2012","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127340_bb0865","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.vaccine.2025.127340_bb0870","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front Oncol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:21:50Z","timestamp":1755897710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":174,"alternative-id":["S0264410X25006371"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127340","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127340"}}